3,6-DIAMINO-PYRIDAZIN-3-YL DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS PRO-APOPTOTIC AGENTS
It is described a compounds of formula (I): a pharmaceutical composition comprising same, for use in the treatment of cancers, of diseases or conditions characterized by an excess or a deregulated activity of platelets. Also provided is the synthesis of intermediate Il est décrit des composés de for...
Saved in:
Main Authors | , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format | Patent |
Language | English French |
Published |
04.02.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | It is described a compounds of formula (I): a pharmaceutical composition comprising same, for use in the treatment of cancers, of diseases or conditions characterized by an excess or a deregulated activity of platelets. Also provided is the synthesis of intermediate
Il est décrit des composés de formule (I) : une composition pharmaceutique connexe à utiliser dans le traitement de cancers, de maladies ou de problèmes caractérisés par un excédent, ou une activité sans régulation, de plaquettes. Il est également décrit la synthèse d'intermédiaires. |
---|---|
AbstractList | It is described a compounds of formula (I): a pharmaceutical composition comprising same, for use in the treatment of cancers, of diseases or conditions characterized by an excess or a deregulated activity of platelets. Also provided is the synthesis of intermediate
Il est décrit des composés de formule (I) : une composition pharmaceutique connexe à utiliser dans le traitement de cancers, de maladies ou de problèmes caractérisés par un excédent, ou une activité sans régulation, de plaquettes. Il est également décrit la synthèse d'intermédiaires. |
Author | TIMARI, MATYAS PAL MADARASZ, ZOLTAN MURRAY, JAMES BROOKE COLLAND, FREDERIC MOLNAR, MARK WEBB, PAUL HERNER, ANDRAS NYERGES, MIKLOS DAVIDSON, JAMES EDWARD PAUL DESOS, PATRICE DODSWORTH, MARK PHILIP STARCK, JEROME-BENOIT PARSONS, RACHEL JANE STROFEK, AGNES PACZAL, ATTILA BEDFORD, SIMON DUNKEL, PETRA RUDASOVA, MONIKA NOVAK, TIBOR SZIGETI, MARIANNA KOTSCHY, ANDRAS CHANRION, MAIA MARAGNO, ANA LETICIA |
Author_xml | – fullname: PARSONS, RACHEL JANE – fullname: MURRAY, JAMES BROOKE – fullname: DUNKEL, PETRA – fullname: RUDASOVA, MONIKA – fullname: MARAGNO, ANA LETICIA – fullname: NYERGES, MIKLOS – fullname: TIMARI, MATYAS PAL – fullname: NOVAK, TIBOR – fullname: HERNER, ANDRAS – fullname: MADARASZ, ZOLTAN – fullname: DODSWORTH, MARK PHILIP – fullname: SZIGETI, MARIANNA – fullname: WEBB, PAUL – fullname: COLLAND, FREDERIC – fullname: BEDFORD, SIMON – fullname: PACZAL, ATTILA – fullname: STROFEK, AGNES – fullname: CHANRION, MAIA – fullname: DAVIDSON, JAMES EDWARD PAUL – fullname: MOLNAR, MARK – fullname: STARCK, JEROME-BENOIT – fullname: DESOS, PATRICE – fullname: KOTSCHY, ANDRAS |
BookMark | eNqNi0sKwjAURTvQgb89vAU0YK2K00cS2wdtEpK0UCelSBxJW6gjV28FF-DongPnrqNFP_RhFb3T-MwEYUlKM9NYEngjxVLWFCCkpRo91dLFYHK0JXJZeeJYANel0Y48aeVmUR5JkcrA57IEVOILZKFy0gE6MFYzNNp4Pd8BM6m820bLR_ecwu63mwiu0vOchXFowzR299CHV8sxTY6X0_6ASfpH8gH8eju5 |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
DocumentTitleAlternate | DERIVES DE 3,6-DIAMINO-PYRIDAZIN-3-YLE, COMPOSITIONS PHARMACEUTIQUES LES CONTENANT ET LEURS UTILISATIONS EN TANT QU'AGENTS PRO-APOPTOTIQUES |
ExternalDocumentID | CA3148502A1 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_CA3148502A13 |
IEDL.DBID | EVB |
IngestDate | Fri Oct 18 05:57:11 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English French |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_CA3148502A13 |
Notes | Application Number: CA20203148502 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210204&DB=EPODOC&CC=CA&NR=3148502A1 |
ParticipantIDs | epo_espacenet_CA3148502A1 |
PublicationCentury | 2000 |
PublicationDate | 20210204 |
PublicationDateYYYYMMDD | 2021-02-04 |
PublicationDate_xml | – month: 02 year: 2021 text: 20210204 day: 04 |
PublicationDecade | 2020 |
PublicationYear | 2021 |
RelatedCompanies | VERNALIS (R&D) LIMITED LES LABORATOIRES SERVIER |
RelatedCompanies_xml | – name: VERNALIS (R&D) LIMITED – name: LES LABORATOIRES SERVIER |
Score | 3.3197098 |
Snippet | It is described a compounds of formula (I): a pharmaceutical composition comprising same, for use in the treatment of cancers, of diseases or conditions... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | 3,6-DIAMINO-PYRIDAZIN-3-YL DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS PRO-APOPTOTIC AGENTS |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210204&DB=EPODOC&locale=&CC=CA&NR=3148502A1 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT8IwEG8IGvVNUSN-pQ-GJxr3xYSHxZRusBnXNdsg4AvZxkh4GURmTPzrvS6AvujbtZc2uWuu1197d0XoQc1VHRxnRvKFqhFD7c5Jz8gVYmiJqcOgJz2V2cg-N92R8TLpTGpoucuFqeqEflbFEcGiMrD3stqv1z-XWHYVW7l5TJfQtXoexJbd2qJjiV9g0e2-5YjADliLMYvRFg8tHY79HUWjAJQO5Claltl3xn2ZlLL-7VEGp-hQwGRFeYZqedFAx2z38VoDHfnb924gt6a3OUdfetskNgBvjwdETEPPpm8eJzqZvmIb0NiYxt7YidpYuDT0KXNGsSx1gFngiyDyqmxhaPCYetzjQxy7jo8ptyXhhXgE-yqmERZhQKgIRBzAcEyHDo-jC4QHTsxcAkLM9gqbMboXV79E9WJV5FcIp2kK_Hm30zMTI9WMxEjmABe07kJJskxVmqj55zTX__Bu0InUfBXKbNyievn-kd-Bpy7T-0rH321sjrw |
link.rule.ids | 230,309,786,891,25594,76903 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT8IwEG8IGvVNUSN-9sHwRCPbyoCHxZRusCrrllEI-EI2GAkvQGTGxL_e2wLoi761vdwl7eXu-mt7V4QetUQzIHBOSTLXdEK15oy0aFIjVI9MA5gaRpxlI3vSdAf0ZVQfFdBilwuT1wn9zIsjgkVNwd7T3F-vfw6x7Pxt5eYpXsDQ6rmjLLuyRccZfgGl223LCXzb5xXOLc4qMrQM2PbXazoDoHTQAESYI6VhO0tKWf-OKJ1TdBiAsGV6hgrJsoSO-e7jtRI68rb33dDcmt7mHH0ZVZPYALyF9EkwDoXN3oQkBhn3sA1obMiUGDr9Kg5cFnqMOwOVlTrA3PcCvy_ybGHoSMWEFLKLlet4mEk7a4gQD8CvYtbHQegTFviB8oEds64jVf8C4Y6juEtgEpP9gk0420_XuETF5WqZXCEcxzHQZ816y4xorNOIRjOAC3pzXoumU61WRuU_xVz_Q3tAx67yepOekK836CTTQv6smd6iYvr-kdxB1E7j-3y9vwE_vZGm |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=3%2C6-DIAMINO-PYRIDAZIN-3-YL+DERIVATIVES%2C+PHARMACEUTICAL+COMPOSITIONS+CONTAINING+THEM+AND+THEIR+USES+AS+PRO-APOPTOTIC+AGENTS&rft.inventor=PARSONS%2C+RACHEL+JANE&rft.inventor=MURRAY%2C+JAMES+BROOKE&rft.inventor=DUNKEL%2C+PETRA&rft.inventor=RUDASOVA%2C+MONIKA&rft.inventor=MARAGNO%2C+ANA+LETICIA&rft.inventor=NYERGES%2C+MIKLOS&rft.inventor=TIMARI%2C+MATYAS+PAL&rft.inventor=NOVAK%2C+TIBOR&rft.inventor=HERNER%2C+ANDRAS&rft.inventor=MADARASZ%2C+ZOLTAN&rft.inventor=DODSWORTH%2C+MARK+PHILIP&rft.inventor=SZIGETI%2C+MARIANNA&rft.inventor=WEBB%2C+PAUL&rft.inventor=COLLAND%2C+FREDERIC&rft.inventor=BEDFORD%2C+SIMON&rft.inventor=PACZAL%2C+ATTILA&rft.inventor=STROFEK%2C+AGNES&rft.inventor=CHANRION%2C+MAIA&rft.inventor=DAVIDSON%2C+JAMES+EDWARD+PAUL&rft.inventor=MOLNAR%2C+MARK&rft.inventor=STARCK%2C+JEROME-BENOIT&rft.inventor=DESOS%2C+PATRICE&rft.inventor=KOTSCHY%2C+ANDRAS&rft.date=2021-02-04&rft.externalDBID=A1&rft.externalDocID=CA3148502A1 |